Gradient Investments LLC Athersys, Inc Transaction History

Gradient Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	BUY	$0.85 - $1.4 $3,400 - $5,600	4,000 Added 9.76%	45,000 $41,000
Q3 2021 Oct 18, 2021	BUY	$1.33 - $1.77 $7,980 - $10,620	6,000 Added 17.14%	41,000 $55,000
Q2 2021 Jul 12, 2021	BUY	$1.41 - $1.94 $14,100 - $19,400	10,000 Added 40.0%	35,000 $50,000
Q1 2021 Apr 21, 2021	BUY	$1.61 - $2.77 $34,293 - $59,001	21,300 Added 575.68%	25,000 $45,000
Q3 2020 Oct 06, 2020	BUY	$1.91 - $3.08 $573 - $924	300 Added 8.82%	3,700 $7,000
Q2 2020 Jul 10, 2020	SELL	$1.97 - $3.98 $8,077 - $16,318	-4,100 Reduced 54.67%	3,400 $9,000
Q1 2020 Apr 07, 2020	BUY	$1.17 - $3.0 $8,775 - $22,500	7,500 New	7,500 $23,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.